More Maradol papayas recalled due to Salmonella risk

ucm575288 More Maradol papayas recalled due to Salmonella riskBravo Produce Inc., of San Ysidro, California, is recalling Maradol papayas, grown by Productores y Exportadores de Carica Papaya de Tecomán y Costa Alegre SPR of RL and packed by Frutas Selectas de Tijuana, S. de RL de CV, because laboratory testing by the Food and Drug Administration (FDA) revealed Salmonella in some of the papayas.

Salmonella is a bacteria that can cause infections that can be serious or life threatening in some people, including children, the elderly and individuals with weakened immune systems. Symptoms include fever, diarrhea, nausea, vomiting and abdominal pain. In rare circumstances, Salmonella infection can result in the organism entering the bloodstream and producing serious diseases including arterial infections (infected aneurysms), endocarditis and arthritis.

The recalled papayas were distributed to wholesale and retail customers within California from Aug. 10 to Aug. 29, 2017, and were available for sale until Aug. 29, 2017. Affected papayas can be identified by the label of the packaging company, Frutas Selectas de Tijuana, S. de R.L. of C.V.

Wholesalers and distributors who received affected papayas have been notified about the recall and instructed to remove and destroy any papayas that are on store shelves and other commercial places. The company is currently working with the FDA to find the source of the contamination.

The recall comes just months after Maradol papayas were linked to dozens of Salmonella infections in 12 states, resulting in hospitalizations and at least one death. The outbreak resulted in the recall of several brands of papayas including the brands Cavi, Valery and Caribena.

Any adverse events related to this recall should be reported to the FDA MedWatch Adverse Event Reporting Program at

FDA Recall Notice
Righting Injustice